Heparin-induced thrombocytopenia--pathogenesis and treatment

Area of Science:

• Pharmacology and Toxicology
• Immunology
• Hematology

Background:

• Heparin-induced thrombocytopenia (HIT) is the most frequent immune-mediated adverse drug reaction.
• Recent advances have elucidated key pathogenic mechanisms of HIT.
• Thrombin generation is recognized as central to the thromboembolic complications in HIT.

Purpose of the Study:

• To review the fundamental aspects of HIT pathogenesis.
• To provide an overview of current therapeutic strategies for HIT.
• To discuss the role of thrombin generation in HIT and its treatment implications.

Main Methods:

• Literature review of recent studies on HIT pathogenesis and treatment.
• Analysis of prospective studies assessing various treatment regimens in HIT.
• Synthesis of current understanding of HIT mechanisms and therapeutic approaches.

Main Results:

• Fundamental aspects of HIT pathogenesis have been resolved in the last decade.
• Thrombin generation is a key factor in clinically manifest HIT.
• Prospective studies offer preliminary treatment recommendations for HIT, despite the absence of randomized trials.

Conclusions:

• Understanding HIT pathogenesis has led to new therapeutic concepts targeting thrombin generation.
• Drugs with anti-thrombin activity, like donaparoid-sodium and lepirudin, are central to new treatment strategies.
• Current evidence from prospective studies allows for preliminary treatment recommendations for HIT.